Modeling intercellular interactions during carcinogenesis

Radiation Research

Volumn 164, Issue 3, 2005, Pages 324-331

  Sachs, Rainer K ^a   Chan, Michael ^b   Hlatky, Lynn ^c   Hahnfeldt, Philip ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; ATOMIC BOMB; BYSTANDER EFFECT; CANCER GROWTH; CELL INTERACTION; CELL PROLIFERATION; HUMAN; IONIZING RADIATION; MALIGNANT TRANSFORMATION; PARSIMONY ANALYSIS; PRECANCER; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION EXPOSURE; STATISTICAL MODEL;

NASA DISCIPLINE RADIATION HEALTH; NON-NASA CENTER;

CARCINOGENICITY TESTS; CELL COMMUNICATION; COMPUTER SIMULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; NEOPLASM PROTEINS; NEOPLASMS, RADIATION-INDUCED; RADIATION DOSAGE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 24144496216     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3413.1     Document Type: Article

References (60)

1. NCRP. Evaluation of the Linear-Nonthreshold Dose-Response Model for Ionizing Radiation. Report No. 136, National Council on Radiation Protection and Measurements. Bethesda, MD. 2001.
2. A. M. Kellerer. Radiation risk-historical perspective and current issues. J. Radiol. Prot. 22, A1-10 (2002).
3. D. J. Brenner, R. Doll, D. T. Goodhead, E. J. Hall, C. E. Land, J. B. Little, J. M. Lubin, D. L. Preston, R. J. Preston and M. Zaider. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc. Natl. Acad. Sci. USA 100, 13761-13766 (2003).
4. E. J. Hall, Henry S. Kaplan Distinguished Scientist Award 2003. The crooked shall he made straight: Dose-response relationships for carcinogenesis. Int. J. Radiat. Biol. 80, 327-337 (2004).
5. D. L. Preston, D. A. Pierce, Y. Shimizu, E. Ron and K. Mabuchi. Dose response and temporal patterns of radiation-associated solid cancer risks. Health Phys. 85, 43-46 (2003).
6. L. Walsh, W. Ruhm and A. M. Kelleren Cancer risk estimates for gamma-rays with regard to organ-specific closes. Part I: All solid cancers combined. Radiat. Environ. Biophys. 43, 145-151 (2004).
7. E. Ron. Cancer risks from medical radiation. Health Phys. 85, 47-59 (2003).
8. J. D. Boice, Jr. and J. H. Lubin. Occupational and environmental radiation and cancer. Cancer Causes Control 8, 309-322 (1997).
9. D. Krewski, J. M. Zielinski, W. D. Hazelton, M. J. Garner and S. H. Moolgavkar. The use of biologically based cancer risk models in radiation epidemiology. Radiat. Prot. Dosim. 104, 367-376 (2003).
10. A. Yakovlev and E. Polig. A diversity of responses displayed by a stochastic model of radiation carcinogenesis allowing for cell death. Math. Biosci. 132, 1-33 (1996).
11. E. G. Wheldon, K. A. Lindsay and T. E. Wheldon. The dose-response relationship for cancer incidence in a two-stage radiation carcinogenesis model incorporating cellular repopulation. Int. J. Radiat. Biol. 76, 699-710 (2000).
12. M. Ohtaki and O. Niwa. A mathematical model of radiation carcinogenesis with induction of genomic instability and cell death. Radiat. Res. 156, 672-677 (2001).
13. S. B. Curtis, E. G. Luebeck, W. D. Hazelton and S. H. Moolgavkar, A new perspective of carcinogenesis from protracted high-LET radiation arises from the two-stage clonal expansion model. Adv. Space Res. 30, 937-944 (2002).
14. W. F. Heidenreich, E. G. Luebeck, W. D. Hazelton, H. G. Paretzke and S. H. Moolgavkar. Multistage models and the incidence of cancer in the cohort of atomic bomb survivors. Radiat. Res. 158, 607-614 (2002).
15. M. P. Little, R. G. Haylock and C. R. Muirhead. Modelling lung tumour risk in radon-exposed uranium miners using generalizations of the two-mutation model of Moolgavkar. Venzon and Knudson. Int. J. Radiat. Biol. 78, 49-68 (2002).
16. M. Mebust, D. Crawford-Brown, W. Hofmann and H. Schollnberger. Testing extrapolation of a biologically based exposure-response model from in vitro to in vivo conditions. Regul. Toxicol. Pharmacol. 35, 72-79 (2002).
17. S. H. Moolgavkar and E. G. Luebeck. Multistage carcinogenesis and the incidence of human cancer. Genes Chromosomes Cancer 38, 302-306 (2003).
18. D. A. Pierce. Mechanistic models for radiation carcinogenesis and the atomic bomb survivor data. Radiat. Res. 160, 718-723 (2003).
19. D. A. Pierce and M. Vaeth. Age-time patterns of cancer to be anticipated from exposure to general mutagens. Biostatistics 4, 231-248 (2003).
20. J. H. Mao, K. A. Lindsay, A. Balmain and T. E. Wheldon, Stochastic modelling of tumorigenesis in p53 deficient mice. Br. J. Cancer 77, 243-252 (1998).
21. K. M. Page and M. A. Nowak. Unifying evolutionary dynamics. J. Theor. Biol. 219, 93-98 (2002).
22. W. Tan. Stochastic Models with Applications to Genetics, Cancers, AIDS, and other Biomedical Systems. World Scientific, London. 2002.
23. R. A. Gatenby and T. L. Vincent. An evolutionary model of carcinogenesis. Cancer Res. 63, 6212-6220 (2003).
24. F. Michor, S. A. Frank, R. M. May, Y. Iwasa and M. A. Nowak. Somatic selection for and against cancer. J. Theor. Biol. 225, 377-382 (2003).
25. N. L. Komurova. Mathematical modeling of tumorigenesis: Mission possible. Curr. Opin. Oncol. 17, 39-43 (2005).
26. A. C. Erickson and M. H. Barcellos-Hoff. The not-so innocent bystander: The microenvironment as a therapeutic target in cancer. Expert Opin. Ther. Targets 7, 71-88 (2003).
27. D. J. Crawford-Brown and W. Hofmann. Extension of a generalized state-vector model of radiation carcinogenesis to consideration of dose rate. Math. Biosci. 115, 123-144 (1993).
28. H. Lodish, A. Berk, P. Matsudaira, C. Kairser, M. Kreiger, M. Scott, S. L. Zipursky and J. Darnell, Molecular Cell Biology. W. H. Freeman, New York. 2004.
29. M. J. Bissell. Modeling Human Risk: Cell and Molecular Biology in Context. Report LBNL-40278. Lawrence Berkeley National Laboratory. Berkeley, CA. 1997.
30. P. Hahnfeldt, D. Panigrahy, J. Folkman and L. Hlatky. Tumor development under angiogenic signaling: A dynamical theory of tumor growth, treatment response, and postvascular dormancy. Cancer Res. 59, 4770-4775 (1999).
31. D. Hanahan and R. A. Weinberg. The hallmarks of cancer. Cell 100, 57-70 (2000).
32. T. Alarcon, H. M. Byrne and P. K. Maini. A cellular automaton model for tumour growth in inhomogeneous environment. J. Theor. Biol. 225, 257-274 (2003).
33. J. P. Kirkpatrick, D. M. Brizel and M. W. Dewhirst. A mathematical model of tumor oxygen and glucose mass transport and metabolism with complex reaction kinetics. Radiat. Res. 159, 336-344 (2003).
34. W. I. Newman and J. A. Lazareff. A mathematical model for self-limiting brain tumors. J. Theor. Biol. 222, 361-371 (2003).
35. V. Quaranta and G. Giannelli. Cancer invasion: Watch your neighbourhood! Tumori 89, 343-348 (2003).
36. J. Folkman and R. Kalluri. Cancer without disease. Nature 427, 787 (2004).
37. M. H. Barcellos-Hoff. Integrative radiation carcinogenesis: interactions between cell and tissue responses to DNA damage. Semin. Cancer Biol. 15, 138-148 (2005).
38. C. E. Land, M. Tokunaga, K. Koyama, M. Soda, D. L. Preston, I. Nishimori and S. Tokuoka. Incidence of female breast cancer among atomic bomb survivors. Hiroshima and Nagasaki. 1950-1990. Radiat. Res. 160, 707-717 (2003).
39. W. F. Heidenreich, P. Jacob and H. G. Paretzke. Exact solutions of the clonal expansion model and their application to the incidence of solid tumors of atomic bomb survivors. Radiat. Environ. Biophys. 36, 45-58 (1997).
40. M. Kai, E. G. Luebeck and S. H. Moolgavkar. Analysis of the incidence of solid cancer among atomic bomb survivors using a two-stage model of carcinogenesis. Radiat. Res. 148, 348-358 (1997).
41. M. Chomentowski, A. M. Kellerer and D. A. Pierce. Radiation dose dependences in the atomic bomb survivor cancer mortality data: A model-free visualization. Radiat. Res. 153, 289-294 (2000).
42. E. G. Luebeck and W. D. Hazelton. Multistage carcinogenesis and radiation. J. Radiol. Prot. 22, A43-49 (2002).
43. W. F. Heidenreich, U. Nyberg and P. Hall. A biologically based model for liver cancer risk in the Swedish Thorotrast patients. Radiat. Res. 159, 656-662 (2003).
44. M. P. Little and E. G. Wright. A stochastic carcinogenesis model incorporating genomic instability fitted to colon cancer data. Math. Biosci. 183, 111-134 (2003).
45. M. P. Little and R. Wakeford. The bystander effect in experimental systems and compatibility with radon-induced lung cancer in humans. J. Radiol. Prot. 22, A27-A31 (2002).
46. D. J. Brenner and R. Sachs. Domestic radon risks may be dominated by bystander effects-but the risks are unlikely to be greater than we thought. Health Phys. 85, 103-108 (2003).
47. R. A. Gatenby and T. L. Vincent. Application of quantitative models from population biology and evolutionary game theory to tumor therapeutic strategies. Mol Cancer Ther. 2, 919-927 (2003).
48. P. D. Holt. Consideration of tissue response in the application of the two-mutation model to radiation carcinogenesis. Int. J. Radiat. Biol. 71, 203-213 (1997).
49. W. F. Heidenreich, M. J. Brugmans, M. P. Little, H. P. Leenhouts, H. G. Paretzke, M. Morin and J. Lafuma. Analysis of lung tumour risk in radon-exposed rats: An intercomparison of multi-step modelling. Radiat. Environ. Biophys. 39, 253-264 (2000).
50. H. Hakoyama and Y. Iwasa. Extinction risk of a meta-population: Aggregation approach. J. Theor. Biol. 232, 203-216 (2005).
51. W. F. Heidenreich. Signals for a promoting action of radiation in cancer incidence data. J. Radiol. Prot. 22, A71-A74 (2002).
52. D. L. Preston, Y. Shimizu, D. A. Pierce, A. Suyama and K. Mabuchi. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat. Res. 160, 381-407 (2003).
53. A. Dewanji, S. H. Moolgavkar and E. G. Luebeck. Two-mutation model for carcinogcnesis: joint analysis of premalignant and malignant lesions. Math. Biosci. 104, 97-109 (1991).
54. W. F. Heidenreich and R. Hoogenveen. Limits of applicability for the deterministic approximation of the two-step clonal expansion model. Risk Anal. 21, 103-105 (2001).
55. T. A. Moger, O. O. Aalen, T. O. Halvorsen, H. M. Storm and S. Tretli. Frailty modelling of testicular cancer incidence using Scandinavian data. Biostatistics 5, 1-14 (2004).
56. C. E. Land, E. Gilbert, J. M. Smith, F. O. Hoffman, I. Apostoiac, B. Thomas and D. Kocher. Report of the NCI-CDC Working Group to Revise the 1985 NIH Radioepidemiological Tables. Publication No. 03-5387. U.S. Department of Health and Human Services. Washington. DC. 2003.
57. V. Jacob and P. Jacob. Modelling of carcinogenesis and low-dose hypersensitivity: An application to lung cancer incidence among atomic bomb survivors. Radiat. Environ. Biophys. 42, 265-273 (2004).
58. D. L. Preston, D. A. Pierce, Y. Shimizu, H. M. Cullings, S. Fujita, S. Funamoto and K. Kodama. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat. Res. 162, 377-389 (2004).
59. L. Walsh, W. Ruhm and A. M. Kellerer. Cancer risk estimates for gamma-rays with regard to organ-specific doses. Part I: All solid cancers combined. Radiat. Environ. Biophys. 43, 145-151 (2004).
60. D. A. Pierce. Age-time patterns of radiogenic cancer risk: their nature and likely explanations. J. Radiol. Prot. 22, A147-A154 (2002).